Skip to main content
TMCI
NASDAQ Industrial Applications And Services

Q1 Revenue Misses, Net Loss Widens Despite EPS Beat Aided by Accounting Change

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$2
Mkt Cap
$124.386M
52W Low
$1.17
52W High
$7.78
52W Position info
71% above low
Off High info
74% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

TMCI sits 71% above its 52-week low of $1.17.

Summary

Treace Medical Concepts reported a Q1 revenue decline and increased net loss, though EPS beat estimates, partly due to an accounting change.


Key Events · Earnings and Guidance · TMCI

  • Q1 2026 Financial Results

    Reported revenue of $47.2 million, a 10.2% decrease from $52.6 million in Q1 2025. Net loss widened to $18.0 million ($0.28 per share) from $15.9 million ($0.25 per share) in Q1 2025.

  • EPS Beat Analyst Expectations

    The reported Q1 EPS loss of $0.28 per share was better than the analyst forecast of a $0.31 per share loss, as previously reported on May 8, 2026.

  • Accounting Estimate Change Impacts Results

    Effective January 1, 2026, the company extended the useful life of capitalized surgical instruments from three to five years, decreasing Q1 depreciation expense by $1.2 million and improving loss per share by $0.02. This change is expected to reduce depreciation by $4.6 million for the full year 2026.

  • Liquidity and Debt Position

    Cash and cash equivalents decreased to $9.5 million from $10.7 million at year-end 2025. The company has access to a $175 million debt facility, with $60 million drawn and an undrawn $30 million revolving loan facility (borrowing base $20.6 million), providing liquidity for at least the next twelve months.


Analysis · TMCI · Industrial Applications And Services

Treace Medical Concepts reported a significant year-over-year revenue decline and a widening net loss for Q1 2026. While the company's reported EPS loss of $0.28 per share was better than analyst expectations, this was partially influenced by a change in accounting estimate for surgical instrument depreciation, which reduced depreciation expense by $1.2 million and improved EPS by $0.02. The company's liquidity position is supported by its $175 million debt facility, with $60 million drawn and additional tranches available, but the underlying operational performance shows challenges in a competitive market. Investors should monitor revenue trends and the impact of new product adoption.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, TMCI was trading at $2.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $124.4M. The 52-week trading range was $1.17 to $7.78. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TMCI - Latest Insights

TMCI
Nov 06, 2026, 7:08 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $4.36
Real-time Price: $4.31 info
Change: -$0.045 (-1%) info
Market Cap: $282.562M info
TMCI
Nov 06, 2026, 7:05 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.25
Real-time Price: $4.31 info
Change: +$0.060 (+1%) info
Market Cap: $282.562M info
TMCI
Nov 06, 2026, 7:05 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $4.36
Real-time Price: $4.31 info
Change: -$0.045 (-1%) info
Market Cap: $282.562M info
TMCI
Sep 17, 2026, 5:16 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.69
Real-time Price: $4.31 info
Change: -$0.380 (-8%) info
Market Cap: $282.562M info
TMCI
Aug 08, 2026, 3:13 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $4.70
Real-time Price: $4.31 info
Change: -$0.390 (-8%) info
Market Cap: $282.562M info